Please use this identifier to cite or link to this item:
|Title:||Irritable bowel syndrome and the Rome III criteria: For better or for worse?||Authors:||Gwee, K.-A.||Keywords:||Functional bowel disorders
Illness behaviour theory
Irritable bowel syndrome
Rome III criteria
|Issue Date:||Jun-2007||Citation:||Gwee, K.-A. (2007-06). Irritable bowel syndrome and the Rome III criteria: For better or for worse?. European Journal of Gastroenterology and Hepatology 19 (6) : 437-439. ScholarBank@NUS Repository. https://doi.org/10.1097/MEG.0b013e328013c0fa||Abstract:||• This is an early evaluation of the Rome III criteria against the Rome II criteria for IBS. • Rigid application of the symptom frequency and duration requirements of the Rome II criteria could have introduced a selection bias for patients with greater psychological disturbance. • Rome III criteria may better reflect the average IBS patient we see in our clinics. • IBS and other functional bowel disorders could be part of a spectrum of similar bowel disturbances rather than distinct entities. • More attention to and interest in the average patient as opposed to the chronically severe patient, may translate into better outcomes in terms of reduction in specialist referral, unnecessary surgery and potentially harmful alternative treatments. The paper by Sperber et al.  in this issue is an early evaluation of the Rome III criteria against the Rome II criteria for irritable bowel syndrome that throws up several important observations. A three to four-fold increase was observed in irritable bowel syndrome prevalence with the Rome III criteria. Individuals with the Rome II criteria had more doctor visits, perception of stress and a negative global feeling. There could be a shift of individuals between irritable bowel syndrome and other functional bowel disorder diagnostic groups such as functional constipation and functional bloating. In this review, it is suggested that rigid application of the symptom frequency and duration requirements of the older Rome criteria could have introduced a selection bias for patients with greater psychological disturbance, and that this could have impacted negatively on our perception and management of irritable bowel syndrome. The findings of Sperber et al. suggest that the new Rome III criteria may enable us to pay more attention to the average irritable bowel syndrome patient we see in our clinics as opposed to the chronically severe patient. It is proposed that improved management of our average patient may translate into better outcomes in terms of reduction in specialist referral, unnecessary surgery and potentially harmful alternative treatments. © 2007 Lippincott Williams & Wilkins, Inc.||Source Title:||European Journal of Gastroenterology and Hepatology||URI:||http://scholarbank.nus.edu.sg/handle/10635/133066||ISSN:||0954691X||DOI:||10.1097/MEG.0b013e328013c0fa|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Oct 15, 2021
WEB OF SCIENCETM
checked on Oct 15, 2021
checked on Oct 14, 2021
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.